glp 1 on medicaid McKee's proposed FY2027 budget drops GLP-1 drugs for weight loss from • Rhode Island Current Medicare, Medicaid will cover GLP-1
Description
According to recent complaints, patients developed non arteritic anterior ischemic optic neuropathy, or NAION, after using the semaglutide based medications
The GLP-1 field has already made meaningful strides in this direction
Furthermore, recent finding reported that GLP-1 RAs significantly reduced C-reactive protein (CRP) levels in obese IBD patients, alongside a nearly statistically significant reduction in fecal calprotectin (100)
Figure 12: Photograph Professor Vincent Marks (1930-2023), credit: Seaton)
